Notes for your stay

  • Masks are no longer compulsory. Anyone who has cold symptoms is asked to test themselves before visiting the UMG and to continue to wear a medical MNS or an FFP2 mask to protect patients and employees even if the test is negative. If the corona test is positive, visitors are not allowed to enter the UMG.
  • It is no longer necessary to present a current, certified negative corona test.


Visiting rules

  • Per patient - two visitors - for two hours per day.
  • Visiting hours on normal wards are from 14:00-19:00 (last admission: 18:30), maternity wards 15:00-18:00.
  • Visiting hours on special and intensive care units may differ. Please check with your ward in advance if necessary.

Thank you for your understanding and cooperation!

The UMG in numbers

1.450

Beds

65.000

Inpatients per year

225.000

Outpatients per year

The University Medical Center Göttingen – what makes us unique

The University Medical Center Göttingen (UMG) is made up of the Medical Faculty with research and teaching and the University Hospital with patient care. The combination of these three areas under one roof is unique in southern Lower Saxony and entails numerous positive interactions, such as the swift transfer of innovative therapy options into patient care and education. We would be pleased to introduce the three areas to you in the following.

Research

Here you can find an overview of our main areas of research, projects and funding opportunities.

Teaching

Learn about degree options, support services and opportunities for PhD and medical doctorates.

Patient care

Here you can find important information about our services to help you plan for your inpatient and outpatient visit.

News

Press release

Halting Weight Loss in Cancer

Researchers at the University Medical Center Göttingen (UMG) discover approach to halt loss of adipose tissue in cancer. Published in Nature Cancer.

Press release

Highest European recognition for early career researchers awarded to three Göttingen Campus academics

The European Research Council (ERC) is funding the three scientists at the Göttingen Campus, Professor Hauke Hillen, Dr Saskia Limbach and Dr Marieke…

Link to Press Release No. 080 / 2023 regarding the subject "How cells age: genes are read faster but less accurately with age"
Press release

How cells age: genes are read faster but less accurately with age

In a joint project co-led by researchers from the University Medical Center Göttingen (UMG), new insights into the aging process have been gained: The…

Link to Press Release No. 075 / 2023 regarding the subject "Chronic kidney disease in children: new drug study"
Press release

Chronic kidney disease in children: new drug study

World's first clinical study examines the efficacy and safety of the kidney-protective drug dapagliflozin in children with chronic kidney disease.…

Link to Press Release No. 069 / 2023 regarding the subject "State of Lower Saxony supports further preclinical development of optical cochlear implants"
Press release

State of Lower Saxony supports further preclinical development of optical cochlear implants

The State of Lower Saxony and the VolkswagenFoundation have granted researchers of the University Medical Center Göttingen, the Leibniz University…

Link to Press Release No. 032 /  2023
Press release

Emilie Macé takes up new professorship for Dynamics of Excitable Cell Networks

Neuroscientist and expert in functional ultrasound bioimaging strengthens research profile of the Cluster of Excellence MBExC.

Join the UMG

We are constantly on the lookout for new employees who will use their passion, enthusiasm and new ideas to drive the UMG forward. Check the vacancies at the UMG or send us a speculative application. We look forward to getting to know you.

Research focuses at the UMG

Neurosciences

Find out more about the Neuroscience research focus at the University Medical Center Göttingen.

Cardiovascular medicine

The clinical and scientific focus at the Heart Center Göttingen is heart failure.

Oncology

The University Cancer Center researches specific cancers and individualized therapies targeting these.

Follow us